Amylyx Pharmaceuticals, Inc. (AMLX) vs CareDx, Inc (CDNA)

A side-by-side comparison of Amylyx Pharmaceuticals, Inc. and CareDx, Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Amylyx Pharmaceuticals, Inc. logo
AMLX
Amylyx Pharmaceuticals, Inc.
$3.09B
$27.78HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CareDx, Inc logo
CDNA
CareDx, Inc
$3.61B
$69.85HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — AMLX vs CDNA

growth of $100 · dividends reinvested · last 5y
AMLX +53.7% (+9.0%/yr)CDNA +78.8% (+12.3%/yr)CDNA compounded faster over this window
050100150200Start $1002023202420252026$154$179
AMLX CDNA

AMLX vs CDNA: by the numbers

  • •CDNA is the larger company ($3.61B vs $3.09B market cap).
  • •CDNA is profitable (24.23% net margin) while AMLX runs a net loss (0.00%).

Metrics side by side

Valuation

MetricAMLXCDNA
P/E ratioN/A33.72
Forward P/EN/A58.32
P/S ratioN/A7.89
P/B ratio12.918.49
EV / EBITDAN/A209.49
FCF yieldN/A2.35%

Profitability

MetricAMLXCDNA
Gross margin0.00%70.58%
Operating margin0.00%-0.92%
Net margin0.00%24.23%
ROE-63.59%26.08%
ROIC-66.60%-0.93%

Growth (annualized)

MetricAMLXCDNA
Revenue CAGR (5Y)N/A12.56%
Total return CAGR (5Y)N/A1.33%

Frequently asked

Is AMLX or CDNA more profitable?
CDNA runs the higher net margin — AMLX at 0.00% versus CDNA at 24.23%.

Go deeper

Full AMLX analysisFull CDNA analysisInteractive comparison tool

Dig into the metrics

CareDx P/E ratioAmylyx Pharmaceuticals ROECareDx ROEAmylyx Pharmaceuticals operating marginCareDx operating marginAmylyx Pharmaceuticals revenue growthCareDx revenue growthAmylyx Pharmaceuticals free cash flowCareDx free cash flow

Amylyx Pharmaceuticals & CareDx appear in these rankings

Highest ROE StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.